Vine Ventures

Lykos Therapeutics aims to transform the approach to mental health by developing innovative medicines and therapeutic methods to address mental health disorders. With over thirty years of experience in researching psychedelic-assisted therapies, the company focuses on the integration of these treatments into the healthcare system. Lykos Therapeutics is dedicated to rigorous scientific standards, working to create and deliver new treatment options that facilitate healing and personal growth for individuals facing mental health challenges.

SpaceVision leverages AI to analyze offline customer engagement, offering targeted marketing strategies for advertisers and retailers.

Tripp Inc. is a company focused on developing a digital psychedelic wellness platform that utilizes virtual and augmented reality to enhance emotional well-being. Founded in 2016 and headquartered in Los Angeles, California, with a satellite office in Chicago, the company creates immersive experiences that combine audio, visual elements, and gameplay mechanics to promote mindfulness and transformation. Tripp’s offerings are informed by scientific research indicating that interactive digital experiences can positively influence brain function. Through its platform, the company delivers wellness solutions designed to help users manage their emotions, reduce stress and anxiety, and achieve a state of calm and focus.

Essor focuses on business tasks such as acquisitions, investments, sourcing, and marketing, allowing third-party seller brands from diverse marketplaces to reach global scale growth. Essor’s brand portfolio today includes a broad range of rapidly growing health & wellness and lifestyle brands like Boka, ZitSticka, Puracy, OTOTO Design, FreshCap, Iron Flask, Fullstar, numnum, Key Nutrients, and Viking Revolution that are sold on Amazon, Direct to Consumer channels, and through national retailers like Target, CVS, and Walmart.

Clerkenwell Health is a mental health company that specializes in providing clinical research support services and psychedelic-assisted therapies, particularly focusing on psilocybin. The company offers a structured course of multi-session therapy, which includes preparation, treatment sessions, and follow-up care conducted by experienced psychotherapists. By employing independent, psychedelic-specialist contract research organization (CRO) services, Clerkenwell Health aims to facilitate the adoption of these innovative treatments throughout Europe. The organization is committed to centering patient needs in clinical trial design and ensuring the delivery of high-quality therapy protocols, ultimately generating robust and clinically validated data to demonstrate the effectiveness of psilocybin-assisted therapy compared to traditional care methods.

Span Health Limited, founded in 2018 and based in London, is a digital care provider focused on improving health outcomes through innovative technology. The company offers a mobile application that facilitates health and fitness tracking, enabling users to monitor their health data and reverse conditions such as diabetes, hyperinsulinemia, and other lifestyle-induced diseases. Span's services include support from healthcare professionals, such as doctors and nutritionists, to guide users in making informed dietary choices that enhance metabolic health and alleviate symptoms associated with conditions like polycystic ovary syndrome, fatty liver disease, and irritable bowel syndrome. By combining technology with personalized care, Span aims to help individuals reduce body fat, manage blood sugar levels, and improve overall well-being.